Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 500201 | NSE Symbol : INDIAGLYCO | ISIN : INE560A01015 | Industry : Breweries & Distilleries |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
28-Jan-2025	04-Feb-2025	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2025 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2024. Kindly find attached. (As per BSE Announcement Dated on 04/02/2025)
30-Oct-2024	07-Nov-2024	Quarterly Results	Quarterly Results Please find attached Incorporation of Wholly Owned Subsidiary of the Company (As Per BSE Announcement dated on 07.11.2024)
21-Sep-2024	21-Sep-2024	Change in Directors	Please find attached update on change in Directorate
22-Jul-2024	29-Jul-2024	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 inter alia to consider and approve Unaudited Financial Results (Standalone & Consolidated) of the Company for the first quarter ended 30th June 2024. Kindly find attached. (As per BSE Announcement Dated on 29/07/2024)
21-May-2024	28-May-2024	Accounts	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March 2024 and recommendation of dividend if any for the financial year ended 31st March 2024. Kindly find attached Recommended a dividend of Rs. 8/- per equity share (@ 80%) of face value of Rs. 10/- each for the financial year ended 31st March, 2024 Kindly find attached (As Per BSE Announcement dated on 28.05.2024)
25-Jan-2024	02-Feb-2024	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2023. The information is being hosted on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 26th December 2023 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Monday 1st January 2024 shall remain closed till Sunday 4th February 2024 (both days inclusive). Please find attached kindly find attached UFR along with LRR for Q3/FY 24 (As per BSE Announcement Dated on 02/02/2024)
27-Oct-2023	03-Nov-2023	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September 2023. The information is being hosted on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 26th September 2023 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Sunday 1st October 2023 shall remain closed till Sunday 5th November 2023 (both days inclusive). Kindly find attached herewith- Change in Senior Management Personnel of the Company. Kindly find attached UFR along with LRR for Q2/FY-24 Kindly find attached update on change in Directorate (As Per BSE Announcement dated on 03.11.2023)
31-Jul-2023	07-Aug-2023	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2023 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the first quarter ended 30th June 2023. The information is being hosted on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 30th June 2023 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Saturday 1st July 2023 shall remain closed till Wednesday 9th August 2023 (both days inclusive). Kindly find attached Results(Standalone and Consolidated) of the Company for the quarter ended 30th June, 2023 Kindly find attached Unaudited Financial Results for Q1/FY24 (As Per BSE Announcement Dated on 07.08.2023)
17-May-2023	24-May-2023	Final Dividend	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 inter alia to consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended 31st March 2023 and recommendation of dividend if any for the financial year ended 31st March 2023. The information is being hosted on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 31st March 2023 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Saturday 1st April 2023 shall remain closed till Friday 26th May 2023 (both days inclusive) Pursuant to Regulation 30 and Schedule Ill of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. 24th May, 2023 has, inter-alia, considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March. 2023. 2. Recommended a dividend of Rs. 7.50/- per equity share (@75%) of face value of Rs. 10/- each for the financial year ended 31st March, 2023 which, if confirmed/declared by the members at the ensuing Annual General Meeting ('AGM'), will be paid/dispatched within 30 days from the date of AGM. The above said Board Meeting commenced at 15:49 Hrs. and concluded at 17:17 Hrs. (As Per BSE Announcement Dated on 24/05/2023)
30-Mar-2023	30-Mar-2023	Others	Pursuant to Regulation 30 and Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform you that the Board of Directors of the Company in its meeting held on 30th March, 2023 has, inter-alia, considered and approved the execution of a Share Purchase Agreement ('SPA') and other relevant transaction documents for sale of Company's entire investment in equity and Preference shares in Subsidiary Company namely Shakumbari Sugar and Allied Industries Limited ('subsidiary company' or 'SSAIL'). The sale of the Company's entire investment in equity shares and preference shares of the Subsidiary Company is contemplated in 1 or more tranches to be completed on or prior to 31 May 2023, subject to terms and conditions (including fulfillment of conditions precedent) of the SPA and other relevant transaction documents.
01-Feb-2023	08-Feb-2023	Quarterly Results	Quarterly Results Further to our letter dated 1st February, 2023 and pursuant to Regulation 30 and Schedule llI of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. 8th February, 2023 has, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31st December, 2022. A copy of above Results along with the Limited Review Reports of Statutory Auditors thereon is enclosed herewith. The above said Board Meeting commenced at 15.15 Hrs. and concluded at 16.25Hrs. This is for your information and records. (As Per BSE Announcement dated on 08.02.2023)
03-Nov-2022	10-Nov-2022	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Thursday 10th November 2022 to inter-alia consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September 2022. The information is being hosted on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 30th September 2022 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Saturday 1st October 2022 shall remain closed till Saturday 12th November 2022 (both days inclusive). This is for your information and records please. Further to letter dtd. 3.11.2022 and pursuant to Reg. 30 and Sch. III of SEBI Listing Regulations, we wish to inform you that the Board in its meeting held today i.e. 10.11.2022 has, inter-alia, considered and approved the following: 1. Unaudited Financial Results (Standalone & Consolidated) of the Company for quarter and half year ended 30.09.2022. The copy of above results along with Limited Review Reports of Statutory Auditors thereon is enclosed as Annexure A. 2. Re-appointment of Shri Sudhir Agarwal (DIN: 08602216) as an Executive Director in the category of whole time director (KMP) of Company, on recommendation of Nomination & Remuneration Committee, for a further period of 1 (one) year w.e.f. 1.12.2022 till 30.11.2023, subject to approval of Members of Company. The Board Meeting commenced at 15.47 Hrs. and concluded at 16.55 Hrs. Further to letter dtd. 3.11.2022 and pursuant to Reg. 30 and Sch. III of SEBI Listing Regulations, we wish to inform you that the Board in its meeting held today i.e. 10.11.2022 has, inter-alia, considered and approved the following: 1. Unaudited Financial Results (Standalone & Consolidated) of the Company for quarter and half year ended 30.09.2022. The copy of above results along with Limited Review Reports of Statutory Auditors thereon is enclosed as Annexure A. 2. Re-appointment of Shri Sudhir Agarwal (DIN: 08602216) as an Executive Director in the category of whole time director (KMP) of Company, on recommendation of Nomination & Remuneration Committee, for a further period of 1 (one) year w.e.f. 1.12.2022 till 30.11.2023, subject to approval of Members of Company. The Board Meeting commenced at 15.47 Hrs. and concluded at 16.55 Hrs. (As per BSE Announcement Dated on 10/11/2022)
02-Aug-2022	09-Aug-2022	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Tuesday 9th August 2022 to inter-alia consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the first quarter ended 30th June 2022. The information is also available on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 30th June 2022 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Friday 1st July 2022 shall remain closed till Thursday 11th August 2022 (both days inclusive). This is for your information and records please. Further to our letter dtd. 02.08.2022 and pursuant to Reg 30 and Schedule III of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. 09.08.2022 has, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the first quarter ended 30.06.2022. The copy of above results along with the Limited Review Reports of Statutory Auditors thereon are enclosed herewith. The above said Board Meeting commenced at 15.43 Hrs. and concluded at 16.56 Hrs. Further to our letter dtd. 02.08.2022 and pursuant to Reg 30 and Schedule III of SEBI Listing Regulations, we wish to inform you that the Board of Directors of the Company in its meeting held today i.e. 09.08.2022 has, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the first quarter ended 30.06.2022. The copy of above results along with the Limited Review Reports of Statutory Auditors thereon are enclosed herewith. The above said Board Meeting commenced at 15.43 Hrs. and concluded at 16.56 Hrs. (As Per BSE Announcement Dated on 09.08.2022)
19-May-2022	26-May-2022	Accounts	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Thursday 26th May 2022 to inter-alia consider and approve the Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and year ended 31st March 2022 and recommendation of dividend if any for the financial year ended 31st March 2022. The information is also available on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 31st March 2022 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Friday 1st April 2022 shall remain closed till Saturday 28th May 2022 (both days inclusive). This is for your information and records please. Further to our letter dtd. 19.05.2022 and pursuant to Reg 30 and Sch III of SEBI LODR, Directors of Company in its meeting held today 26.05.2022 has approved, inter-alia, following: 1. Audited Financial Results (Standalone & Consolidated) for qtr & year ended 31.03.2022. Results, Auditor's Report & declaration are enclosed as Annexure A. 2. Recommended a dividend of Rs. 7.50/- per equity share (@75%) of face value of Rs. 10 each for FY 22 which, if confirmed/declared by members at ensuing AGM, will be paid/dispatched within 30 days from the date of AGM. 3. Re-appointment of K.N. Gutgutia & Co., Chartered Accountants (Reg. No. 304153E) as Statutory Auditors of Company, subject to approval of members in ensuing AGM, for the second term of 5 years, to hold office from conclusion of 38th AGM until the conclusion of 43rd AGM. Their brief profile is enclosed as Annexure B. The above said Board Meeting commenced at 16.15 Hrs. and concluded at 18.20 Hrs. (As Per BSE Announcement Dated on 26.05.2022) The Board of Directors at its meeting held on 26th May, 2022 recommended a Final dividend at Rs. 7.50/- (75%) per equity share of the face value of Rs. 10/- each for FY 2021-22, subject to the approval of Shareholders at the ensuing 38th Annual General Meeting and shall be paid after deduction of tax at the prescribed rates. Pursuant to provisions of the Income Tax Act, 1961 (Act), as amended by the Finance Act, 2020, dividend paid or distributed by a Company on or after 1st April, 2020 shall be taxable in the hands of the shareholders, therefore, the Company is required to deduct tax at source at the time of making payment of dividend at the prescribed rates. In this regard, please find enclosed herewith an email communication which has been sent to all the shareholders whose e-mail addresses are registered with the Company/ Depositories, inter-alia, elaborating the process and documentation required. We request you to kindly take the above on record. Thanking you, (As per BSE Announcement Dated on 05/08/2022)
04-Feb-2022	11-Feb-2022	Quarterly Results	INDIA GLYCOLS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that a Meeting of the Board of Directors of the Company will be held on Friday 11th February 2022 to inter-alia consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December 2021. The information is also available on the Companys website at www.indiaglycols.com. Further as intimated vide our letter dated 31st December 2021 pursuant to the Companys Code of Conduct for Regulating Monitoring and Reporting Trading in Securities the 'Trading Window' for trading in the shares of the Company which has been closed for Designated Persons from Saturday 1st January 2022 shall remain closed till Sunday 13th February 2022 (both days inclusive). This is for your information and records please. Further to letter dtd. 4.02.2022 and pursuant to Reg 30 and Sch III of SEBI Listing Regulations, we wish to inform you that the Board in its meeting held today i.e. 11.02.2022 has, inter-alia, considered and approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31.12.2021. The copy of above results along with the Limited Review Reports of Statutory Auditors thereon are enclosed herewith. The Board Meeting commenced at 15.22 Hrs. and concluded at 17.08 Hrs. (As per BSE Announcement Dated on 11/02/2022)

1 2

LOGIN HERE

India Glycols Ltd

Board Meeting